This report - which is available individually or as part of a full subscription to Global PV Tracker - examines the trends and opportunities in patient caseloads and procedure volumes in urological surgery markets.
Urological surgery includes a wide range of open and minimally invasive procedures performed on the urological organs for indications including kidney stones, benign prostatic hypertrophy, prostate cancer, kidney cancer and urinary obstruction. The primary types of urological surgery procedures are kidney stone removal procedures including extracorporeal shock wave lithotripsy (ESWL), percutaneous nephrolithotripsy (PCNL), ureteroscopy, open kidney stone procedures, transurethral prostatectomy, other surgeries for treatment of benign prostatic hypertrophy, prostatectomy, nephrectomy, urological endoscopy procedures such as cystoscopy and cystectomy, and urethral catheterizations of the bladder. In 2017, the number of urological surgery procedures performed worldwide totaled approximately 43.2 million. The number of procedures per year is forecast to grow at a 2.3% compound annual rate over the 2017-2022 interval, with volume exceeding 48.3 million by 2022. The rate of growth is significantly greater than the growth rate for the combined population of the 37 countries analyzed in this report of 0.7% per year.
QUESTIONS ANSWERED IN THIS REPORT:
DATABOOK: Buyers of this report also receive an Excel dashboard containing urological surgery procedure forecasts segmented by global, region (4) and country (32).
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
